Q4 2022 13F Holders as of 31 Dec 2022
-
Type / Class
-
Equity / Stock
-
Total 13F shares
-
6,051,567
-
Share change
-
-1,783,653
-
Total reported value
-
$1,210,218
-
Price per share
-
$0.20
-
Number of holders
-
40
-
Value change
-
-$1,870,878
-
Number of buys
-
19
-
Number of sells
-
20
Institutional Holders of Ginkgo Bioworks Holdings, Inc. - Stock (DNABW) as of Q4 2022
As of 31 Dec 2022,
Ginkgo Bioworks Holdings, Inc. - Stock (DNABW) was held by
40 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
6,051,567 shares.
The largest 10 holders included
CVI Holdings, LLC, Ionic Capital Management LLC, MORGAN STANLEY, Altshuler Shaham Ltd, GUGGENHEIM CAPITAL LLC, Walleye Capital LLC, COWEN AND COMPANY, LLC, Johnson Financial Group, LLC, Skandinaviska Enskilda Banken AB (publ), and Chescapmanager LLC.
This page lists
40
institutional shareholders reporting positions in this security
for the Q4 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.